Advance directives and the impact of timing. A qualitative study with Swiss general practitioners. by Otte, I.C. et al.
Original article | Published 2 October 2014, doi:10.4414/smw.2014.14035
Cite this as: Swiss Med Wkly. 2014;144:w14035
Advance directives and the impact of timing
A qualitative study with Swiss general practitioners
Ina Carola Ottea,b, Corinna Jungb, Bernice Simone Elgera, Klaus Ballyb
a Institute for Biomedical Ethics, University of Basel, Switzerland
b Institute of Primary Health Care, University of Basel, Switzerland
Summary
PRINCIPLES: Advance directives are seen as an important
tool for documenting the wishes of patients who are no
longer competent to make decisions in regards to their
medical care. Due to their nature, approaching the subject
of advance directives with a patient can be difficult for both
the medical care provider and the patient. This paper fo-
cuses on general practitioners’ perspectives regarding the
timing at which this discussion should take place, as well
as the advantages and disadvantages of the different mo-
ments.
METHODS: In 2013, 23 semi-structured face-to-face in-
terviews were performed with Swiss general practitioners.
Interviews were analysed using qualitative content analys-
is.
RESULTS: In our sample, 23 general practitioners
provided different options that they felt were appropriate
moments: either (a) when the patient is still healthy, (b)
when illness becomes predominant, or (c) when a patient
has been transferred to a long-term care facility. Further-
more, general practitioners reported uncertainty and dis-
comfort regarding initiating the discussion.
CONCLUSION: The distinct approaches, perspectives and
rationales show that there is no well-defined or “right” mo-
ment. However, participants often associated advance dir-
ectives with death. This link caused discomfort and uncer-
tainty, which led to hesitation and delay on the part of gen-
eral practitioners. Therefore we recommend further train-
ing on how to professionally initiate a conversation about
advance directives. Furthermore, based on our results and
experience, we recommend an early approach with healthy
patients paired with later regular updates as it seems to be
the most effective way to inform patients about their end-
of-life care options.
Key words: advance directives; general practice; decision
making; advance care planning; patient-centred care;
primary health care
Introduction
Advance directives are written documents which give pa-
tients the opportunity to outline the treatments that they
do or do not wish to receive if a future situation renders
them unable to make decisions regarding their medical
care [1, 2] (for an example of an advance directive form
see: http://www.fmh.ch/files/pdf11/
PV_e_Ausfuehrliche_Version.pdf [last access: March
2014]). Recently, the focus on patient autonomy and the
wide variety of modern medical interventions have led to a
substantial debate about advance directives [1, 3–5]. Topics
of discussion include whether advance directives are valu-
able tools for assessing personal values [6, 7] and wheth-
er or not advance directives can express the will of differ-
ent patient groups in situations in which communication or
competent decision making is no longer possible [8–10].
Additionally, the possibility of bias based upon vague lan-
guage or unclear phrasing in an advance directive have
been discussed [11].
Several qualitative studies have shown that most general
practitioners (GPs) appreciate the positive impact that ad-
vance directives have on patients, families and health pro-
fessionals [12–15]. For Switzerland, Harringer’s study of
Swiss patients in 2012 showed that 70% of patients who
had no advance directive would be willing to draft one with
the assistance of their general practitioner [16]. At the be-
ginning of 2013, the legal status of advance directives has
been strengthened via the new adult protection law (Ger-
man: Erwachsenenschutzgesetz, see http://www.admin.ch/
ch/d/as/2011/725.pdf). This law now includes a passage
that makes the application of any treatment described as
unwanted in an advance directive a physical assault which
can result in criminal charges brought against whoever de-
livered the unwanted treatment. Since advance directives
have become stronger and the penalties associated with ig-
noring them have become more severe due to the changes
in the law, it is of the utmost imperative that possible biases
be minimised. While many aspects of advance directives
have been discussed in recent decades, the proper time to
address the topic with patients has not received sufficient
attention.
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As part of a continuing research project on the conditions
and quality of end of life care in Switzerland, the authors
conducted a series of interviews with Swiss general practi-
tioners to explore their views on palliative care in general
and specifically regarding how advance directives should
be facilitated and implemented. Based on the insights given
during these interviews, we hypothesise that both the
phrasing of an advance directive as well as the timing of its
drafting plays a crucial role in its effectiveness to protect
the patient’s wishes [11]. Therefore, this research paper fo-
cuses on one of the four main themes that emerged from the
analysis of the interviews in more detail: on general prac-
titioners ’perspectives about the best moment to initiate a
discussion about the creation of an advance directive. In
addition, it highlights general practitioners’ reasoning for
different timings as well as advantages and disadvantages
of each of these timings.
Methods
This paper references results from a Switzerland-wide
study entitled “Conditions and Quality of End-of-Life Care
in Switzerland – the role of general practitioners which was
funded by the Swiss National Science Foundation (addi-
tional papers from this research study are currently under
review and not published yet). The aim of this study is to
conduct a detailed exploration of the functions of general
practitioners who administer palliative care in primary
practice. As one of the two steps of the qualitative section
of the study, 23 qualitative interviews with general practi-
tioners were conducted and analysed.
Sampling and data collection
Purposive sampling was chosen in order to obtain a diverse
selection of physicians working in different types of prac-
tices (group versus single), regions (different cantons, rural
versus urban region etc.), with a variety of gender, age,
and professional experience characteristics. A total of 30
general practitioners were purposively selected from the
FMH (Swiss Medical Association) list (Swiss wide cata-
logue of physicians, available on the website ht-
tp://www.doctorfmh.ch/ contains 30000 entries), in order
to represent the major characteristics of the Swiss popula-
tion of general practitioners (proportional quota sampling).
Participants were contacted via e-mail outlining the re-
search. The email contained information about the title of
the study “conditions and quality of end-of-life care in
Switzerland – the role of general practitioners”, informa-
tion about the foundation which financed the study and in-
formation about the approximate length of the interviews,
as well as the invitation to participate. In a one-hour (ap-
proximate) face-to-face interview in their surgeries, parti-
cipants answered questions about administering palliative
care in a primary care setting. Besides the interviewers and
the interviewee nobody else was present during the inter-
view. The interviews were recorded from December 2012
to February 2013 using Audacity software (audacity soft-
ware is a free audio editor and recorder, more information
available on the website http://audacity.sourceforge.net/
about/). Among question sets about administering palliat-
ive care and their networking with other institutions and
stakeholders, they were also asked about the meaning of
advance directives for their work. Additional questions ex-
plored when and how this topic was approached with their
patients. The interview guideline was pilot tested and was
adapted during the first interviews. The interviews were
conducted by IO and CJ (both authors of this paper), both
sociologists who have long term experience with qualitat-
ive methods. The French interviews were conducted by a
Swiss-French nurse who is also trained in qualitative meth-
ods. Interviews were transcribed verbatim in the origin-
al language of the interviewees (French and several Swiss
German dialects) and were analysed with the support of the
analysis programme atlas.ti, Version 7.0. Participants were
given the opportunity to review their interview transcripts.
However, no participant made use of this option. A repeti-
tion of one or more interviews was not necessary.
Analysis
The analysis of all transcripts (mainly in their original lan-
guage, some passages have been translated since not all au-
thors are fluent in French) was conducted by four members
of the research team (all authors included) with different
disciplinary backgrounds (sociology, general practice and
palliative care experts). The coders followed Mayring’s
nine steps of content analysis [17, 18], (1.) the relevant data
was defined, (2.) the context of appearance of the data re-
gistered, (3.) a formal characterisation of the data mater-
ial described, (4.) the course of analysis specified, (5.) a
theory-lead differentiation checked, (6.) technique of ana-
lysis defined (summarisation, explication, structuring), (7.)
the unit of analysis defined, (8.) data material analysed,
and (9.) finally interpreted. The data was repeatedly coded,
moving from concrete passages to more abstract level of
coding, deriving themes from the data and searching for re-
peating concepts. In team meetings all findings were critic-
ally tested and discussed by all coders. Any disagreements
were solved by discussion. Since the coding system re-
mained the same for the last interviews and since the find-
ings regarding timing did not significantly add something
new to the interviews before, we conclude that we reached
saturation with our number of interviews.
The study was approved by Basel Ethics Committee (Nr.
EK 248/12) prior to its initiation. The informed consent
of all participants was obtained and the interviewed physi-
cians were given anonymity.
Results
Of the 30 general practitioners who were invited to par-
ticipate, 23 physicians from French, Italian and German
speaking regions in Switzerland agreed to participate (pos-
itive respond rate of 76%). From the seven GPs who
dropped out of the study, one GP who initially wanted to
participate was excluded because he was acquainted with
the research team. Our sample therefore consisted of 14
German-speaking physicians (two of them practising in an
Italian speaking region) with a mean age of 54.2 years
(range from 43 to 62) and nine French-speaking physicians
aged 52.6 years on average (range from 37 to 63). All par-
ticipants (23/23) stated that advance directives are very im-
portant tools for their work, especially for learning about
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patients’ values. However, it was also stated by some par-
ticipants that the available forms that are often used to cre-
ate an advance directive are too short or too hypothetical
in their content. A total of 17 of the participants (17/23)
shared more in-depth thoughts on advance directives. From
their answers four main themes emerged: (1.) the import-
ance of advance directives for Swiss general practitioners;
(2.) the proper time to discuss the composition of an ad-
vance directive; (3.) who should bring up the topic of ad-
vance directives and (4.) how the advance directives should
be worded in order to best protect the wishes of the patient.
Of these four themes, the proper time for general practi-
tioners to discuss the drafting of an advance directive (AD)
is the main focus of this research paper.
Different “right” timings of an advance directive
Through the interviews, we identified three main trends re-
garding how general practitioners determine the appropri-
ate moment to discuss an advance directive with a patient:
(a) slightly more than half (9/17) of the interviewed gen-
eral practitioners reported that they usually create advance
directives with their patients when they are still healthy
while (b) the rest (8/17) create advance directives with pa-
tients both while they are healthy but mainly when they are
already suffering from a terminal disease. Some of these
general practitioners (3/8) additionally stated that they
would consider a possible change of perspective if a pre-
viously healthy patient became seriously ill. They also be-
lieve that advance directives should regularly be adapted
to best meet the patient’s current condition. Additionally,
some general practitioners utilised (c) systematic ap-
proaches, such as age or during the first consultation with a
patient, in their decision to discuss advance directives with
healthy patients or patients with a severe illness. Anoth-
er important point stated by general practitioners was that
they are doubtful whether the available and often used ad-
vance directives forms contain enough information to en-
able them to make a justified treatment decision:
– GP 11: “When I fill in an advance directive with my
patients, I always advise them to make a lot of changes
to the available template, because especially the longer
form includes so many situations that are highly
hypothetical and very abstract, it does not make any
sense to fill it in.”
– GP 10: “Well, so there is a form from the FMH (Swiss
Medical Association), it is very short and here is a
longer form. So the longer one, I always use that for
the patients, but I find these situations highly
hypothetical and very abstract, so I often see no sense
in that (the form which GP10 is referring to is
accessible through www.fmh.ch/services/
patientenverfuegung.html).
Approach (a) “Sufficiently early” (before illness)
The majority of the interviewees (9/17) considered advance
directives as a source of discomfort if they are not written
“early enough”. Different reasons were given for why they
think that it is important to write an advance directive be-
fore an emergency or a terminal illness occurs. Some re-
spondents mentioned that advance directives filled out dur-
ing an emergency situation could be distorted by stress
and would thus not properly reflect the patient’s will. This
could also become an additional source of discomfort:
– GP 13:It is very important to be able to draft one
because you have to write it before you are in an
emergency, because in an emergency the decisions you
could make are not always obvious, whether it is for us
or for others involved. I think it is even harder for
others at the moment when decisions have to be made.
So I think this can be a source of extreme discomfort,
whether it’s for us dealing with such a situation if
things haven’t been settled in advance. Because, does
a person, in an emergency, give us directives [that are]
related to the emergency? Are they related to their
physical suffering? Well, there are so many things
which can intervene. And then we can also end up in
conflict with the family, who may not see things the
same way at all. So I think it’s really, really important
to address this early. To have a clearer idea and to
agree that the direction that we take is the direction
that everyone would like us to take.
Additionally, this general practitioner emphasised the pos-
sible conflicts for relatives in the decision making process,
especially in the absence of an advance directive. The in-
terviewee explained further that sufficient time is required
to discuss the patient’s wishes with the family to avoid fu-
ture conflicts. If an advance directive is written during an
emergency situation, the lack of time could lead to conflicts
involving all parties.
Another stated reason to fill in advance directives “suffi-
ciently early”, was the feeling of unease when having to
talk to already terminally ill patients about this subject:
– GP 4: So, I talk to them and ask if they have an advance
directive, and I also say that it is always good to start
thinking about it before it is necessary, because, if a
patient is already terminally ill, it is much more
uncomfortable to talk about this topic.
– GP 2: I really have inhibitions to talk to a severely ill
patient, who is still in a critical state, about this topic.
So I always try to cover this topic early enough,
ideally sufficiently early, before a critical state can
occur.
Approach (b) “When illness becomes predominant”
In contrast, a large number of interviewees (8/17) stated
their doubts that it is possible to draw an advance directive
with a healthy patient because the patient cannot imagine
his or her future situation where an illness has become ter-
minal:
–GP 17: Advance directives are something where I would
take an hour or even two hours or time to talk
repeatedly with the patients to know what they want
and try to understand how they picture things. The
problem with advance directives when we write them
with patients, who are still healthy, is that they can’t
picture things.
Approach (c) as part of organisational and administrative
requirements
Health and illness were not the only determinants of when
to draft an advance directive. Another moment to draw up
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advance directives that was frequently named was the mo-
ment of transferring the patient to a nursing home.
– GP 20: I often have to fill in an advance directive with a
patient before I can transfer him or her to another
institution such as a hospice or a nursing home. (...)
More and more institutions make advance directives a
mandatory requirement, which often results in what I
call “last minute” advance directives.
– GP 9: In our canton, everyone who wants to move to a
nursing home has to have an advance directive.
Discussion
Approach (a) “Sufficiently early” (before illness)
The majority of the interviewed general practitioners fol-
lowed the approach “sufficiently early (before illness oc-
curs)”. They stated that they did so to avoid biases that
can occur when advance directives are drafted during an
emergency situation; to prevent the patient from additional
stress; and to avoid the feeling of discomfort caused by dis-
cussing the approaching death with terminally ill patients.
This third argument is already known from other studies
[1, 19, 20]. This finding is also in line with studies where
patients indicated the discussion about advance directives
should occur earlier in age, earlier in the progression of the
disease or even earlier in the relationship between physi-
cian and patient in general [19, 21, 22].
Since the wish of patients to draft an advance directive
often gains importance with the progression of a disease
[23, 24], the approach of only talking to healthy patients
may require reconsideration. As also mentioned by the in-
terviewees patient’s preferences given during healthy days
may not be very stable since patients are not always cap-
able of imaging what their decisions will be when a disease
becomes predominant [25–27]. Therefore, it is important
to use advance directives as a precautionary measure and
to give patients the opportunity to update advance direct-
ives later on during the course of their disease. This is an
important ethical necessity to make sure that treatment de-
cisions are still in line with the actual preferences later on
in the course of the disease [23, 28].
General practitioners participating in this study mentioned
updates of advance directives only in very rare cases (3/
17). While the mentioned concern that the conversation
might put a strain on the patient is understandable, the op-
tion for the patient to update the advance directive may
provide a feeling of comfort due to the patient having a
say in what will happen in the future. The chance to define
which treatments they want to receive in future situations
may also reduce the feeling of the loss of autonomy as well
as their dependency upon others [16].
Some respondents stated that the first step towards raising
the topic is still often very difficult for many of them, es-
pecially when the patient is in need of palliative treatment.
They reported feeling a sense of unease and stated to re-
frain from informing already ill patients because they fear
talking about dying and approaching death could be a fur-
ther burden upon their patients.
Fallowfield et al. described that healthcare professionals
often censor their information given to patients in an at-
tempt to protect them from potentially hurtful, sad or bad
news. They showed a commonly expressed belief that what
people do not know does not harm them. However, it has
to be noted that the desire to shield patients from this topic
may create even greater difficulties or harm for patients, re-
latives or involved healthcare professionals [29].
Our results show that the interviewed GPs consider ad-
vance directives to be strongly connected to forthcoming
death, the main focus of advance directives might need re-
consideration. Following different definitions of advance
directives, the main focus of an advance directive is often
described as giving the patients the opportunity to specify
what actions should be taken for their health if they are
no longer able to make decisions for themselves because
of illness or incapacity – which is not necessarily related
to upcoming death. We as authors therefore support that
the first discussion about an advance directive should focus
mainly on exactly this: on future treatment choices, but
not necessarily on dying or death itself. Additional training
could help general practitioners to phrase conversations
about advance directives in a way that gives patients a
sense that advance directives are a mean to ensure their
own autonomy. This way discomfort on both sides could be
minimised, which could contribute to an open and honest
patient-physician-relationship.
Approach (b) “When illness becomes predominant”
The second approach [2] to informing patients, when ill-
ness becomes predominant, stands in direct contrast to that
stated above. Earlier survey data [30] shows that also other
general practitioners think only severely ill patients in an
advance stage of their disease are capable of formulating
stable preferences for their end-of-life care. One motivator
for this approach that was mentioned by the interviewees
was the fear that patients will record treatment preferences
(and refusals) that are not in line with their actual prefer-
ences later on [31]. It was also shown by other studies that
patients are more open to discussions about advance direct-
ives when death is already approaching [24, 32].
Our data shows that this general practitioners’ association
of advance directives with approaching death strongly in-
fluenced the choice of the moment in which participating
general practitioners inform their patients about advance
directives. Therefore their patients often receive little in-
formation about advance directives until symptoms occur
that make a conversation about an advance directive inevit-
able. This may lead to advance directives that only repres-
ent a form of written consent to withhold certain treatments
or a downgraded advance directive that only reflects anoth-
er version of DNR orders as seen in the study from Burch-
ardi et al. [31]. For this reason it is necessary to emphasise
that advance directives are an opportunity to extensively
describe the patient’s preferences concerning different life-
sustaining technologies for distinct states of health [31].
Furthermore, from an ethical perspective, advance direct-
ives are designed to be completed as an extensive pre-
cautionary measure which implies continuously refinement
and modification via updates [31].
Another aspect that was mentioned by our interviewees and
that needs consideration is that due to the sometimes rap-
id progress of diseases, the time between the occurrence of
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symptoms and the patient’s inability to communicate might
be too short for the patients to make reasoned decisions.
As a result, patients might actually miss the opportunity to
make their own decision and convey their preferences [31].
An important point stated by general practitioners was that
they are doubtful whether advance directives forms contain
enough information to enable them to make a justified
treatment decision. Interviewed general practitioners men-
tioned that especially in difficult situations, medical
decision-making can only be guided by advance directives
which are specific and as concrete as possible.
However, the ethical ideal that the completion of advance
directives should be embedded in discussions between
physicians and patients [31] may turn out to be problematic
in practice. Limited time resources or timing pressures dur-
ing consultations [33] in combination with our respondents
stating that the available advance directive forms are too
short and/or too hypothetical may fail to provide enough
room for a broad and comprehensive discussion about ad-
vance directives. Since literature shows that patients who
are facing a severe illness also find it acceptable to be in-
formed by admitting physicians, oncologists or other health
care professionals, even if they are meeting for the first
time [34], the outsourcing of advance directives consulta-
tions to avoid timing pressures might be a possible solu-
tion.
Approach (c) as part of organisational and
administrative requirements
The third approach included the moment when advance
directives are drafted because the patient wants or has to
be moved to a nursing home. A few general practitioners
mentioned that they have to draw up an advance directive
before they are able to transfer a patient to a nursing home,
due to their institutional requirements. However, in this
case the requirements of advance directives seem to be
more present than the wish to understand the patients’ val-
ues regarding medical decisions in the future. Furthermore,
making an advance directive an institutional requirement
can be ethically problematic, since it should be drawn up
without pressure and based on the free will of the patient
(this is also noted in the guidelines of the Swiss Academies
of Medical Sciences (SAMS): http://www.samw.ch/en/Eth-
ics/Guidelines/Currently-valid-guidelines.html). Therefore
a discussion of advance directives should not be confused
with coercion to fill out documents, especially if the goals
of the document do not coincide with the goals of the resid-
ent. If a resident is not ready to make decisions at the time
of admission, the topic of advance directives and advance
care planning should be raised at a later date [35].
For this reason, we conclude that the approach to make ad-
vance directives a mandatory requirement has the same dis-
advantages as seen above because the advance directive of-
ten needs to be drafted in a short amount of time (to meet
the administrative requirement in order to become a resid-
ent), and is often based on hypothetical forms. This com-
bination has the risk of drawing up a biased and incomplete
advance directive that fails to provide a basis for a justified
medical decision making.
Strengths and limitations
One clear strength of this study is the use of a qualitative
method to explore a multifaceted topic, in which general
practitioners could express how they integrate advance dir-
ectives in their practice. However, due to the qualitative
design, representative conclusions cannot be drawn.
Furthermore, the study sample may not have represented
the full range of general practitioners’ views on this topic,
since it was limited in regards to geographical and cultural
variation. Also other selection biases due to the recruitment
process are possible, since the study was announced under
the title of “conditions and quality of end-of-life care in
Switzerland – the role of general practitioners”. This an-
nouncement could have especially selected physicians who
feel confident regarding palliative care and/or advance care
planning.
Furthermore, because our results rely on only one data
source, triangulation from other methods of data collection
such as group discussion or a survey may increase the
validity of the results. For this reason, the next step of our
study is to design a large-scale questionnaire to quantify the
results that we obtained from the interviews. (The results
of the large-scale questionnaire will be available in summer
2014.)
Therefore, we are convinced, that even despite these lim-
itations, the obtained findings already show a variety of
well-differentiated attitudes which add significant know-
ledge about how advance directives are implemented in
general practice.
Conclusions/implications for practice
The general practitioners interviewed in our study ex-
pressed three main approaches to the discussion of advance
directives: (1.) when the patient is still healthy, (2.) when
illness becomes predominant and (3.) systematically when
a certain event occurs (such as the first consultation, the
transfer to another institution or the patient reaching a cer-
tain age). Some of the participants mentioned that the cur-
rent forms used to create advanced directives utilised ques-
tions and scenarios that are too vague to properly convey
patient’s wishes. Updates of advance directives were only
rarely mentioned by participating general practitioners (3/
17).
We as authors therefore reach the conclusion that, in line
with our results and the existing literature, GPs preferably
a) initiate the first conversation about ADs early enough,
when the patient is still healthy, to gain a clear
understanding of a patient’s desires in terms of their
medical care
b) update advance directives regularly since it is known
that treatment preferences can change with the time
c) reaffirm a patients’ wishes as their illness and medical
care progress.
We also conclude that GPs should refrain from drafting ad-
vance directives to meet institutional or organisational re-
quirements because it offers the risk of compromising the
free will of the patient. This could lead to the drawing up
of a biased and incomplete advance directive that fails to
provide a basis for a justified medical decision making.
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